PROCESS FOR PRODUCING ORALLY ADMINISTRABLE PHARMACEUTICAL COMPOSITIONS COMPRISING COAGULATION AND PLATELET FUNCTION INHIBITING ACTIVE INGREDIENTS IN SMALL DOSE

摘要

There are disclosed combination products useful for the treatment and/or prevention of a first or recurrent myocardial infarction or a first or recurrent stroke. Said combination products comprise low doses of an oral anticoagulant, preferably warfarin and platelet inhibiting agents, including non-steroidal antiinflammatory agents and preferrably aspirin.